Breaking News Instant updates and real-time market news.

AMP

Ameriprise

$251.17 /

+1.9 (+0.76%)

16:13
07/26/21
07/26
16:13
07/26/21
16:13

Ameriprise reports Q2 EPS $5.27, consensus $5.20

Reports Q2 revenue $3.42B, consensus $3.36B. CEO Jim Cracchiolo says: "Ameriprise delivered a strong second quarter and a record first half in operating revenue, earnings and EPS, as we continue to build on our momentum. We are delivering an excellent client experience and deepening relationships, which is driving continued growth in the business. "In the quarter, nearly 80% of revenue and pretax earnings were driven by our asset-light Advice and Wealth Management and Asset Management businesses. We also announced a number of important strategic actions, including the acquisition of BMO's EMEA asset management business and a significant reinsurance transaction. Together, these moves complement our organic growth while also adding key capabilities and generating shareholder value."

  • 27

    Jul

AMP Ameriprise
$251.17 /

+1.9 (+0.76%)

07/08/21 UBS
Ameriprise price target raised to $300 from $285 at UBS
06/18/21 Citi
Everest Re downgraded to Neutral on valuation at Citi
04/28/21 RBC Capital
Ameriprise price target raised to $295 from $270 at RBC Capital
04/12/21 Barclays
Ameriprise price target raised to $265 from $245 at Barclays

TODAY'S FREE FLY STORIES

Hot Stocks
Bridge Specialty Group announces asset acquisition of Gremesco of New Jersey » 06:48
09/20/21
09/20
06:48
09/20/21
06:48
BRO

Brown & Brown

$56.96 /

-0.495 (-0.86%)

Brown & Brown and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BRO Brown & Brown
$56.96 /

-0.495 (-0.86%)

BRO Brown & Brown
$56.96 /

-0.495 (-0.86%)

08/16/21 Wolfe Research
Brown & Brown initiated with a Peer Perform at Wolfe Research
07/27/21 Keefe Bruyette
Keefe Bruyette boosts Brown & Brown target on 'stronger' organic growth
04/28/21 Deutsche Bank
Brown & Brown price target raised to $55 from $50 at Deutsche Bank
04/28/21 RBC Capital
Brown & Brown price target raised to $53 from $48 at RBC Capital
BRO Brown & Brown
$56.96 /

-0.495 (-0.86%)

BRO Brown & Brown
$56.96 /

-0.495 (-0.86%)

Hot Stocks
Pfizer, BioNTech announce results from trial of COVID-19 vaccine in children » 06:47
09/20/21
09/20
06:47
09/20/21
06:47
PFE

Pfizer

$43.89 /

-0.57 (-1.28%)

, BNTX

BioNTech

$358.75 /

-13.75 (-3.69%)

Pfizer Inc. (PFE) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$43.89 /

-0.57 (-1.28%)

BNTX BioNTech
$358.75 /

-13.75 (-3.69%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

06:31 Today Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
BNTX BioNTech
$358.75 /

-13.75 (-3.69%)

09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
08/27/21 UBS
BioNTech price target raised to $300 from $111 at UBS
08/20/21 Canaccord
BioNTech price target raised to $450 from $240 at Canaccord
08/12/21 Wells Fargo
Wells says Moderna vaccine looks more effective than Pfizer's against Delta
PFE Pfizer
$43.89 /

-0.57 (-1.28%)

BNTX BioNTech
$358.75 /

-13.75 (-3.69%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

BNTX BioNTech
$358.75 /

-13.75 (-3.69%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

BNTX BioNTech
$358.75 /

-13.75 (-3.69%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

Recommendations
Molina Healthcare price target raised to $305 from $284 at Mizuho » 06:45
09/20/21
09/20
06:45
09/20/21
06:45
MOH

Molina Healthcare

$278.12 /

+8.09 (+3.00%)

Mizuho analyst Ann Hynes…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MOH Molina Healthcare
$278.12 /

+8.09 (+3.00%)

MOH Molina Healthcare
$278.12 /

+8.09 (+3.00%)

09/09/21 Cowen
Molina Healthcare initiated with an Outperform at Cowen
09/08/21 Mizuho
Selloff in managed care sector overdone, says Mizuho
07/30/21 BMO Capital
Molina Healthcare price target raised to $315 from $300 at BMO Capital
07/30/21 Mizuho
Molina Healthcare price target raised to $284 from $273 at Mizuho
MOH Molina Healthcare
$278.12 /

+8.09 (+3.00%)

MOH Molina Healthcare
$278.12 /

+8.09 (+3.00%)

Recommendations
Sale of Voyager more likely than out-licensing, says Benchmark » 06:45
09/20/21
09/20
06:45
09/20/21
06:45
VYGR

Voyager Therapeutics

$3.13 /

+0.09 (+2.96%)

Over the last two weeks…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VYGR Voyager Therapeutics
$3.13 /

+0.09 (+2.96%)

VYGR Voyager Therapeutics
$3.13 /

+0.09 (+2.96%)

08/11/21 Benchmark
Voyager Therapeutics price target lowered to $9 from $20 at Benchmark
07/09/21 Chardan
Voyager Therapeutics coverage transferred at Chardan
05/20/21 Benchmark
Voyager Therapeutics' 'three-point value' remains despite exits, says Benchmark
04/26/21 Wedbush
Wedbush sees FDA clearance of IND for VY-HTT01 as 'clear positive' for Voyager
VYGR Voyager Therapeutics
$3.13 /

+0.09 (+2.96%)

General news
FX Action: USD-CAD lifted by over 0.5% in posting a one-month high » 06:45
09/20/21
09/20
06:45
09/20/21
06:45
$ECON

Economic Data

/

+

FX Action: USD-CAD lifted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

Hot Stocks
Aerie appoints Erik Pacyniak as director, toxicology, drug disposition » 06:39
09/20/21
09/20
06:39
09/20/21
06:39
AERI

Aerie Pharmaceuticals

$12.84 /

+0.495 (+4.01%)

Aerie Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AERI Aerie Pharmaceuticals
$12.84 /

+0.495 (+4.01%)

AERI Aerie Pharmaceuticals
$12.84 /

+0.495 (+4.01%)

11/09/20 H.C. Wainwright
Aerie Pharmaceuticals price target lowered to $29 from $31 at H.C. Wainwright
10/28/20 H.C. Wainwright
Aerie Pharmaceuticals $50M upfront should reduce overhang, says H.C. Wainwright
10/19/20 BofA
Aerie Pharmaceuticals downgraded to Underperform from Neutral at BofA
10/19/20 BofA
Aerie Pharmaceuticals downgraded to Underperform from Neutral at BofA
AERI Aerie Pharmaceuticals
$12.84 /

+0.495 (+4.01%)

AERI Aerie Pharmaceuticals
$12.84 /

+0.495 (+4.01%)

Initiation
Li-Cycle initiated with an Outperform at Wedbush » 06:39
09/20/21
09/20
06:39
09/20/21
06:39
LICY

Li-Cycle

$8.77 /

+0.09 (+1.04%)

Wedbush analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LICY Li-Cycle
$8.77 /

+0.09 (+1.04%)

LICY Li-Cycle
$8.77 /

+0.09 (+1.04%)

09/13/21 Morgan Stanley
Li-Cycle initiated with an Overweight at Morgan Stanley
09/09/21 BMO Capital
Li-Cycle initiated with an Outperform at BMO Capital
08/23/21 Baird
Baird starts Li-Cycle at Neutral, sees 'discounted multiple' as warranted
08/23/21 Baird
Li-Cycle initiated with a Neutral at Baird
LICY Li-Cycle
$8.77 /

+0.09 (+1.04%)

LICY Li-Cycle
$8.77 /

+0.09 (+1.04%)

LICY Li-Cycle
$8.77 /

+0.09 (+1.04%)

Hot Stocks
ChromaDex announces preclincal research findings from CERP » 06:38
09/20/21
09/20
06:38
09/20/21
06:38
CDXC

ChromaDex

$6.75 /

+0.44 (+6.97%)

ChromaDex announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CDXC ChromaDex
$6.75 /

+0.44 (+6.97%)

CDXC ChromaDex
$6.75 /

+0.44 (+6.97%)

08/04/21 H.C. Wainwright
ChromaDex price target raised to $12 from $11 at H.C. Wainwright
06/07/21 H.C. Wainwright
ChromaDex sales momentum should accelerate, says H.C. Wainwright
03/16/21 H.C. Wainwright
ChromaDex price target raised to $16 from $7 at H.C. Wainwright
03/08/21 B. Riley Securities
ChromaDex price target raised to $18 from $7 at B. Riley Securities
CDXC ChromaDex
$6.75 /

+0.44 (+6.97%)

CDXC ChromaDex
$6.75 /

+0.44 (+6.97%)

CDXC ChromaDex
$6.75 /

+0.44 (+6.97%)

Hot Stocks
Sanofi reports Libtayo Phase 3 trial met primary, key secondary endpoints » 06:38
09/20/21
09/20
06:38
09/20/21
06:38
SNY

Sanofi

$48.35 /

+0.14 (+0.29%)

, REGN

Regeneron

$651.38 /

-2.3 (-0.35%)

Phase 3 results for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SNY Sanofi
$48.35 /

+0.14 (+0.29%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

SNY Sanofi
$48.35 /

+0.14 (+0.29%)

06:31 Today Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
09/14/21 Mizuho
Kadmon downgraded to Neutral from Buy at Mizuho
09/10/21 UBS
Kadmon downgraded to Neutral from Buy at UBS
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
REGN Regeneron
$651.38 /

-2.3 (-0.35%)

09/15/21 Cantor Fitzgerald
Regeneron price target raised to $700 from $670 at Cantor Fitzgerald
09/15/21 H.C. Wainwright
Regeneron price target raised to $831 from $787 at H.C. Wainwright
09/15/21 Piper Sandler
Regeneron price target raised to $690 from $675 at Piper Sandler
09/09/21
Fly Intel: Top five analyst initiations
SNY Sanofi
$48.35 /

+0.14 (+0.29%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

SNY Sanofi
$48.35 /

+0.14 (+0.29%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

SNY Sanofi
$48.35 /

+0.14 (+0.29%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

Hot Stocks
Synlogic announces data from studies evaluating SYNB1618, SYNB1934 » 06:38
09/20/21
09/20
06:38
09/20/21
06:38
SYBX

Synlogic

$3.25 /

+0.06 (+1.88%)

Synlogic announced data…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SYBX Synlogic
$3.25 /

+0.06 (+1.88%)

SYBX Synlogic
$3.25 /

+0.06 (+1.88%)

07/09/21 Chardan
Synlogic assumed with a Buy at Chardan
06/28/21 H.C. Wainwright
Synlogic price target lowered to $9 from $13 at H.C. Wainwright
03/25/21 SVB Leerink
Synlogic price target raised to $15 from $10 at SVB Leerink
03/18/21 JonesTrading
Synlogic initiated with a Buy at JonesTrading
SYBX Synlogic
$3.25 /

+0.06 (+1.88%)

  • 16
    Apr
SYBX Synlogic
$3.25 /

+0.06 (+1.88%)

Recommendations
Personalis Veterans Affairs contract smaller than expected, says Citi » 06:37
09/20/21
09/20
06:37
09/20/21
06:37
PSNL

Personalis

$22.34 /

+1.25 (+5.93%)

Citi analyst Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PSNL Personalis
$22.34 /

+1.25 (+5.93%)

PSNL Personalis
$22.34 /

+1.25 (+5.93%)

08/05/21 Citi
Personalis price target lowered to $30 from $37 at Citi
05/13/21 Truist
Personalis price target lowered to $29 from $37 at Truist
05/06/21 Oppenheimer
Personalis upgraded to Outperform at Oppenheimer on multi-year growth cycle
05/06/21 Oppenheimer
Personalis upgraded to Outperform from Perform at Oppenheimer
PSNL Personalis
$22.34 /

+1.25 (+5.93%)

  • 27
    Jan
PSNL Personalis
$22.34 /

+1.25 (+5.93%)

Hot Stocks
Adagio Therapeutics expands patient population in EVADE Phase 2/3 trial » 06:36
09/20/21
09/20
06:36
09/20/21
06:36
ADGI

Adagio Therapeutics

$51.51 /

-4.46 (-7.97%)

The independent data…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADGI Adagio Therapeutics
$51.51 /

-4.46 (-7.97%)

08/31/21
Fly Intel: Top five analyst initiations
08/31/21 Guggenheim
Adagio Therapeutics initiated with a Buy at Guggenheim
08/31/21 Stifel
Adagio Therapeutics initiated with a Buy at Stifel
08/31/21 Jefferies
Adagio Therapeutics initiated with a Buy at Jefferies
ADGI Adagio Therapeutics
$51.51 /

-4.46 (-7.97%)

  • 06
    Aug
ADGI Adagio Therapeutics
$51.51 /

-4.46 (-7.97%)

General news
Oil prices have dropped back » 06:35
09/20/21
09/20
06:35
09/20/21
06:35
$ECON

Economic Data

/

+

Oil prices have dropped…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

Earnings
Adagio Therapeutics reports Q2 EPS (18c) vs. (66c) last year » 06:34
09/20/21
09/20
06:34
09/20/21
06:34
ADGI

Adagio Therapeutics

$51.51 /

-4.46 (-7.97%)

"Across the globe,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADGI Adagio Therapeutics
$51.51 /

-4.46 (-7.97%)

08/31/21
Fly Intel: Top five analyst initiations
08/31/21 Guggenheim
Adagio Therapeutics initiated with a Buy at Guggenheim
08/31/21 Stifel
Adagio Therapeutics initiated with a Buy at Stifel
08/31/21 Jefferies
Adagio Therapeutics initiated with a Buy at Jefferies
  • 06
    Aug
ADGI Adagio Therapeutics
$51.51 /

-4.46 (-7.97%)

Hot Stocks
Brown & Brown announces asset acquisition of AGIS Network » 06:33
09/20/21
09/20
06:33
09/20/21
06:33
BRO

Brown & Brown

$56.96 /

-0.495 (-0.86%)

Brown & Brown and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BRO Brown & Brown
$56.96 /

-0.495 (-0.86%)

BRO Brown & Brown
$56.96 /

-0.495 (-0.86%)

08/16/21 Wolfe Research
Brown & Brown initiated with a Peer Perform at Wolfe Research
07/27/21 Keefe Bruyette
Keefe Bruyette boosts Brown & Brown target on 'stronger' organic growth
04/28/21 Deutsche Bank
Brown & Brown price target raised to $55 from $50 at Deutsche Bank
04/28/21 RBC Capital
Brown & Brown price target raised to $53 from $48 at RBC Capital
BRO Brown & Brown
$56.96 /

-0.495 (-0.86%)

BRO Brown & Brown
$56.96 /

-0.495 (-0.86%)

Hot Stocks
Brooks Automation to sell semiconductor solutions group business for $3B » 06:32
09/20/21
09/20
06:32
09/20/21
06:32
BRKS

Brooks Automation

$94.21 /

+1.46 (+1.57%)

Brooks Automation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BRKS Brooks Automation
$94.21 /

+1.46 (+1.57%)

BRKS Brooks Automation
$94.21 /

+1.46 (+1.57%)

09/07/21 KeyBanc
Brooks Automation price target raised to $146 from $115 at KeyBanc
05/11/21 Needham
Brooks Automation price target raised to $130 from $110 at Needham
05/11/21 Credit Suisse
Brooks Automation price target raised to $85 from $70 at Credit Suisse
05/11/21 B. Riley
Brooks Automation price target raised to $130 from $125 at B. Riley
BRKS Brooks Automation
$94.21 /

+1.46 (+1.57%)

BRKS Brooks Automation
$94.21 /

+1.46 (+1.57%)

BRKS Brooks Automation
$94.21 /

+1.46 (+1.57%)

Hot Stocks
Thomas H. Lee to acquire automation business from Brooks Automation for $3B » 06:32
09/20/21
09/20
06:32
09/20/21
06:32
BRKS

Brooks Automation

$94.21 /

+1.46 (+1.57%)

Thomas H. Lee Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BRKS Brooks Automation
$94.21 /

+1.46 (+1.57%)

BRKS Brooks Automation
$94.21 /

+1.46 (+1.57%)

09/07/21 KeyBanc
Brooks Automation price target raised to $146 from $115 at KeyBanc
05/11/21 Needham
Brooks Automation price target raised to $130 from $110 at Needham
05/11/21 Credit Suisse
Brooks Automation price target raised to $85 from $70 at Credit Suisse
05/11/21 B. Riley
Brooks Automation price target raised to $130 from $125 at B. Riley
BRKS Brooks Automation
$94.21 /

+1.46 (+1.57%)

BRKS Brooks Automation
$94.21 /

+1.46 (+1.57%)

BRKS Brooks Automation
$94.21 /

+1.46 (+1.57%)

Recommendations
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote » 06:31
09/20/21
09/20
06:31
09/20/21
06:31
PFE

Pfizer

$43.89 /

-0.57 (-1.28%)

, AZN

AstraZeneca

$55.56 /

-1.04 (-1.84%)

, ABBV

AbbVie

$107.75 /

-0.33 (-0.31%)

, BMY

Bristol-Myers

$61.32 /

+0.1 (+0.16%)

, RHHBY

Roche

$46.07 /

-0.75 (-1.60%)

, NVO

Novo Nordisk

$101.45 /

-0.945 (-0.92%)

, SNY

Sanofi

$48.35 /

+0.14 (+0.29%)

Despite Friday's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$43.89 /

-0.57 (-1.28%)

AZN AstraZeneca
$55.56 /

-1.04 (-1.84%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

NVO Novo Nordisk
$101.45 /

-0.945 (-0.92%)

SNY Sanofi
$48.35 /

+0.14 (+0.29%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
09/15/21 Raymond James
Exact Sciences' 'opportunistic' hires should boost sales, says Raymond James
AZN AstraZeneca
$55.56 /

-1.04 (-1.84%)

09/17/21 Evercore ISI
Innate Pharma price target raised to $10 from $6 at Evercore ISI
09/17/21 Morgan Stanley
AstraZeneca price target raised to 10,000 GBp from 9,800 GBp at Morgan Stanley
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
08/12/21 JPMorgan
AstraZeneca resumed with an Overweight at JPMorgan
ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

09/14/21 Barclays
Regenxbio price target raised to $82 from $79 at Barclays
09/13/21 Chardan
Regenxbio pact with AbbVie accelerates RGX-314 'value capture,' says Chardan
09/08/21 JPMorgan
AbbVie offers 'best risk/reward story in the group,' says JPMorgan
09/07/21 Morgan Stanley
Morgan Stanley cuts Vertex Pharmaceuticals to Underweight amid AbbVie overhang
BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
07/27/21 Mizuho
Bristol-Myers deal a positive signal about BridgeBio's BBP-398, says Mizuho
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
RHHBY Roche
$46.07 /

-0.75 (-1.60%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/07/21 UBS
Roche price target raised to CHF 350 from CHF 345 at UBS
08/02/21 JPMorgan
Roche price target raised to CHF 360 from CHF 310 at JPMorgan
07/27/21 Societe Generale
Roche price target raised to CHF 353 from CHF 340 at Societe Generale
NVO Novo Nordisk
$101.45 /

-0.945 (-0.92%)

09/03/21 Berenberg
Novo Nordisk price target raised to DKK 530 from DKK 430 at Berenberg
08/23/21 Credit Suisse
Novo Nordisk price target raised to DKK 625 from DKK 470 at Credit Suisse
08/23/21 Citi
Novo Nordisk price target raised to DKK 780 from DKK 510 at Citi
08/17/21 UBS
Novo Nordisk price target raised to DKK 630 from DKK 447 at UBS
SNY Sanofi
$48.35 /

+0.14 (+0.29%)

09/14/21 Mizuho
Kadmon downgraded to Neutral from Buy at Mizuho
09/10/21 UBS
Kadmon downgraded to Neutral from Buy at UBS
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/09/21 Benchmark
Sanofi deal for Kadmon reinforces Incyte thesis, says Benchmark
PFE Pfizer
$43.89 /

-0.57 (-1.28%)

AZN AstraZeneca
$55.56 /

-1.04 (-1.84%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

NVO Novo Nordisk
$101.45 /

-0.945 (-0.92%)

SNY Sanofi
$48.35 /

+0.14 (+0.29%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

AZN AstraZeneca
$55.56 /

-1.04 (-1.84%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

SNY Sanofi
$48.35 /

+0.14 (+0.29%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

AZN AstraZeneca
$55.56 /

-1.04 (-1.84%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

NVO Novo Nordisk
$101.45 /

-0.945 (-0.92%)

SNY Sanofi
$48.35 /

+0.14 (+0.29%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

AZN AstraZeneca
$55.56 /

-1.04 (-1.84%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

General news
FOMC forecasts » 06:30
09/20/21
09/20
06:30
09/20/21
06:30
$ECON

Economic Data

/

+

FOMC forecasts to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

Hot Stocks
Eros STX Global bondholders approve amendment to extend maturity date » 06:29
09/20/21
09/20
06:29
09/20/21
06:29
ESGC

Eros STX Global

/

+

Eros STX Global announces…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ESGC Eros STX Global
/

+

ESGC Eros STX Global
/

+

ESGC Eros STX Global
/

+

Recommendations
NRG Energy removed from US 1 List at BofA  06:27
09/20/21
09/20
06:27
09/20/21
06:27
NRG

NRG Energy

$42.07 /

-0.93 (-2.16%)

 
ShowHide Related Items >><<
NRG NRG Energy
$42.07 /

-0.93 (-2.16%)

NRG NRG Energy
$42.07 /

-0.93 (-2.16%)

06/27/21 Goldman Sachs
NRG Energy upgraded to Conviction Buy from Buy at Goldman Sachs
06/21/21 Seaport Global
NRG Energy price target raised to $47 from $42 at Seaport Global
03/18/21
Fly Intel: Top five analyst downgrades
03/18/21 Morgan Stanley
NRG Energy price target lowered to $51 from $59 at Morgan Stanley
NRG NRG Energy
$42.07 /

-0.93 (-2.16%)

NRG NRG Energy
$42.07 /

-0.93 (-2.16%)

Hot Stocks
SmileDirectClub up 15% in pre-market trading at $7.71 per share » 06:27
09/20/21
09/20
06:27
09/20/21
06:27
SDC

SmileDirectClub

$6.70 /

+0.705 (+11.76%)

Shares of SmileDirectClub…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SDC SmileDirectClub
$6.70 /

+0.705 (+11.76%)

SDC SmileDirectClub
$6.70 /

+0.705 (+11.76%)

08/13/21
Fly Intel: Top five analyst downgrades
08/13/21 Wolfe Research
SmileDirectClub downgraded to Peer Perform from Outperform at Wolfe Research
08/10/21
Fly Intel: Top five analyst downgrades
08/10/21 Loop Capital
SmileDirectClub price target lowered to $6 from $9 at Loop Capital
SDC SmileDirectClub
$6.70 /

+0.705 (+11.76%)

  • 24
    Nov
  • 19
    Nov
SDC SmileDirectClub
$6.70 /

+0.705 (+11.76%)

SDC SmileDirectClub
$6.70 /

+0.705 (+11.76%)

SDC SmileDirectClub
$6.70 /

+0.705 (+11.76%)

Recommendations
Adobe shares may be pricing in front office tailwinds, says Citi » 06:26
09/20/21
09/20
06:26
09/20/21
06:26
ADBE

Adobe

$655.09 /

-10.26 (-1.54%)

Citi analyst Tyler Radke…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADBE Adobe
$655.09 /

-10.26 (-1.54%)

ADBE Adobe
$655.09 /

-10.26 (-1.54%)

09/17/21 Mizuho
Adobe price target raised to $695 from $640 at Mizuho
09/16/21 BMO Capital
Adobe price target raised to $730 from $630 at BMO Capital
09/16/21 Barclays
Adobe price target raised to $740 from $660 at Barclays
09/15/21 Morgan Stanley
Adobe price target raised to $736 from $610 at Morgan Stanley
ADBE Adobe
$655.09 /

-10.26 (-1.54%)

ADBE Adobe
$655.09 /

-10.26 (-1.54%)

ADBE Adobe
$655.09 /

-10.26 (-1.54%)

ADBE Adobe
$655.09 /

-10.26 (-1.54%)

Hot Stocks
Rocky Mountain Chocolate sends letter to stockholders » 06:24
09/20/21
09/20
06:24
09/20/21
06:24
RMCF

Rocky Mountain Chocolate

$7.80 /

+ (+0.00%)

Rocky Mountain Chocolate…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RMCF Rocky Mountain Chocolate
$7.80 /

+ (+0.00%)

Initiation
i-80 Gold initiated with an Outperform at RBC Capital » 06:23
09/20/21
09/20
06:23
09/20/21
06:23
IAUCF

i-80 Gold

$2.38 /

-0.02 (-0.83%)

RBC Capital analyst Wayne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IAUCF i-80 Gold
$2.38 /

-0.02 (-0.83%)

IAUCF i-80 Gold
$2.38 /

-0.02 (-0.83%)

09/08/21 Canaccord
i-80 Gold price target raised to C$5.50 from C$3.75 at Canaccord
09/08/21 Scotiabank
i-80 Gold price target raised to C$4.25 from C$3.75 at Scotiabank
05/20/21 Stifel
i-80 Gold initiated with a Buy at Stifel
05/12/21 Canaccord
i-80 Gold initiated with a Buy at Canaccord

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.